Cart
sales@molnova.com
2-Methoxybenzoic acid
CAS No. 579-75-9
2-Methoxybenzoic acid( o-Anisic acid | NSC 3778 | O-Methylsalicylic acid | Salicylic acid methyl ether )
Catalog No. M20594 CAS No. 579-75-9
2-Methoxybenzoic acid is a novel antiemetic which prevents nausea and vomiting in humans.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 26 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name2-Methoxybenzoic acid
-
NoteResearch use only, not for human use.
-
Brief Description2-Methoxybenzoic acid is a novel antiemetic which prevents nausea and vomiting in humans.
-
Description2-Methoxybenzoic acid is a novel antiemetic which prevents nausea and vomiting in humans.
-
In Vitro——
-
In Vivo——
-
Synonymso-Anisic acid | NSC 3778 | O-Methylsalicylic acid | Salicylic acid methyl ether
-
PathwayProteasome/Ubiquitin
-
TargetEndogenous Metabolite
-
RecptorHuman Endogenous Metabolite
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number579-75-9
-
Formula Weight152.15
-
Molecular FormulaC8H8O3
-
Purity>98% (HPLC)
-
SolubilityDMSO:30 mg/mL (197.17 mM)
-
SMILESCOc1ccccc1C(O)=O
-
Chemical NameBenzoic acid 2-methoxy-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
5,6-Dihydrouridine
5,6-Dihydrouridine, a modified base, is located in conserved positions within the D-loop of tRNA in Eukaryota, Bacteria, and some Archaea.
-
D-Glucose-13C6
D-Glucose-13C6 (Dextrose-13C6) is an isotopic marker of D-Glucose, which can be used as a metabolic tracer for the study of metabolism-related diseases and metabolic processes of some substances in the body.
-
Glucagon-Like Peptid...
Glucagon-like peptide 2 (GLP-2) is a recently identified intestinal epithelium-specific growth factor that has been shown to reduce the severity of inflammatory disorders of the intestine in rodent models. Currently Glucagon-Like Peptide 2 is used as a potential therapeutic agent for the human subjects with a broad variety of intestinal diseases characterized by intestinal damage and insufficiency.
